- Feb 24, 2017
- 2 min
DMD Therapeutics Inc. Receives Funding from DMD Foundations to Develop DMD-813 for Treatment of Duch
SEATTLE, Feb. 24 2017 /PRNewswire/ -- DMD Therapeutics, Inc., a start-up biotech company, is developing proprietary therapeutics for Duchenne muscular dystro...
- Jun 18, 2015
- 3 min
NEWS: Akashi Therapeutics Reports Positive Clinical Data on HT-100 in Patients with Duchenne Muscula
Interim Clinical Data from Ongoing Phase 1b/2a Clinical Program Highlights Statistically Significant Improvements in Muscle Strength Cambridge, Mass. - June ...